1. Home
  2. DHX vs KROS Comparison

DHX vs KROS Comparison

Compare DHX & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHI Group Inc.

DHX

DHI Group Inc.

HOLD

Current Price

$4.73

Market Cap

178.0M

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.48

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHX
KROS
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.0M
206.0M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
DHX
KROS
Price
$4.73
$11.48
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$6.25
$21.86
AVG Volume (30 Days)
300.2K
156.2K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.00
EPS
0.10
N/A
Revenue
$127,826,000.00
$243,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
$2,751.79
P/E Ratio
$48.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$9.69
52 Week High
$5.19
$22.55

Technical Indicators

Market Signals
Indicator
DHX
KROS
Relative Strength Index (RSI) 58.14 55.27
Support Level $3.80 $10.57
Resistance Level $4.79 $11.61
Average True Range (ATR) 0.27 0.40
MACD 0.02 -0.00
Stochastic Oscillator 61.91 62.50

Price Performance

Historical Comparison
DHX
KROS

About DHX DHI Group Inc.

DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: